12-49022633-C-T
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong
The NM_003482.4(KMT2D):c.16295G>A(p.Arg5432Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R5432W) has been classified as Pathogenic.
Frequency
Consequence
NM_003482.4 missense
Scores
Clinical Significance
Conservation
Publications
- choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndromeInheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Illumina, G2P
- Kabuki syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
- branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Kabuki syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KMT2D | ENST00000301067.12 | c.16295G>A | p.Arg5432Gln | missense_variant | Exon 52 of 55 | 5 | NM_003482.4 | ENSP00000301067.7 | ||
| ENSG00000288710 | ENST00000683988.1 | n.266G>A | non_coding_transcript_exon_variant | Exon 2 of 16 | ENSP00000506939.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Kabuki syndrome 1 Pathogenic:1
- -
KMT2D-related disorder Pathogenic:1
The KMT2D gene is constrained against variation (Z-score= 4.7 and pLI = 1), and missense variants are a common mechanism of disease (HGMD, ClinVar database; PMID: 21882399, 30107592). The c.16295G>A (p.Arg5432Gln) variant affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. This is a recurrent variant that has been previously reported as a heterozygous change in patients with Kabuki syndrome (PMID: 36891680, 30107592, 31654559, 32803813, 32850830, 27302555). It has been reported in the de novo state (PMID: 37043208, 25896430, 31654559, 32170002) and as co-segregating with disease in a familial case (PMID: 22740433). A different amino acid change at the same residue (p.Arg5432Trp) has been previously reported in individuals with Kabuki syndrome (PMID: 33057194, 34374989, 22786791). The c.16295G>A (p.Arg5432Gln) variant is absent from the gnomAD v4 population database and thus is presumed to be rare. Analysis of the parental samples was negative for the variant, indicating this variant likely occurred as a de novo event. Based on the available evidence, c.16295G>A (p.Arg5432Gln) is classified as Pathogenic. -
not provided Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at